News coverage about Sientra (NASDAQ:SIEN) has been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sientra earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned headlines about the medical instruments supplier an impact score of 45.8535238546166 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Shares of Sientra (SIEN) opened at 15.40 on Friday. The firm’s 50-day moving average is $11.65 and its 200-day moving average is $9.52. The firm’s market cap is $297.31 million. Sientra has a 1-year low of $6.92 and a 1-year high of $16.49.

Sientra (NASDAQ:SIEN) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported ($0.55) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.59) by $0.04. The company had revenue of $8.20 million for the quarter, compared to analyst estimates of $6.97 million. Sientra had a negative return on equity of 52.30% and a negative net margin of 173.83%. Sientra’s revenue for the quarter was up 32.3% on a year-over-year basis. On average, analysts anticipate that Sientra will post ($2.94) EPS for the current fiscal year.

A number of research firms have weighed in on SIEN. Stifel Nicolaus reiterated a “hold” rating and set a $14.00 price target (up previously from $11.00) on shares of Sientra in a research note on Wednesday. William Blair upgraded shares of Sientra from a “market perform” rating to an “outperform” rating in a research note on Wednesday, September 13th. Canaccord Genuity began coverage on shares of Sientra in a research note on Monday, August 28th. They set a “buy” rating and a $14.00 price target on the stock. Zacks Investment Research downgraded shares of Sientra from a “hold” rating to a “sell” rating in a research note on Tuesday, August 15th. Finally, Lake Street Capital reiterated a “buy” rating and set a $15.00 price target (up previously from $11.00) on shares of Sientra in a research note on Tuesday, August 8th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $13.75.

ILLEGAL ACTIVITY WARNING: “Sientra (SIEN) Receiving Somewhat Positive Media Coverage, Accern Reports” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at

Sientra Company Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Insider Buying and Selling by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.